» Articles » PMID: 3690228

Prognostic Factors Related to Survival and Groin Recurrence Following Therapeutic Lymph Node Dissection for Lower Limb Malignant Melanoma

Overview
Journal Br J Surg
Specialty General Surgery
Date 1987 Nov 1
PMID 3690228
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

A retrospective analysis was carried out of 133 patients undergoing therapeutic lymph node dissection for malignant melanoma of the lower limb. A radical ilio-obturator dissection (RID) was performed in 106 patients and a superficial femoral dissection (SFD) in the remaining 27. On univariate analysis five factors were found to be significant indicators of prognosis. These were: Clark level of the primary (P = 0.02); primary melanoma thickness (P = 0.04); total number of positive nodes (P less than 0.001); number of positive femoral nodes (P less than 0.001); and number of positive ilio-obturator nodes (P less than 0.001). On multiple regression analysis only the number of positive nodes in each compartment remained a significant independent factor (P less than 0.001). The morbidity associated with RID was not significantly greater than after SFD. RID was, however, associated with a reduction in subsequent groin recurrence. Radical nodal clearance is the operation of choice. This technique provides maximum prognostic information, reduces the likelihood of local untreatable disease and possibly improves overall survival rates--especially when only one iliac node is involved.

Citing Articles

Nodal Basin Recurrence After Sentinel Lymph Node Biopsy for Melanoma: A Retrospective Multicenter Study in 2653 Patients.

Kretschmer L, Bertsch H, Zapf A, Mitteldorf C, Satzger I, Thoms K Medicine (Baltimore). 2015; 94(36):e1433.

PMID: 26356697 PMC: 4616624. DOI: 10.1097/MD.0000000000001433.


Superficial and deep lymph node dissection for stage III cutaneous melanoma: clinical outcome and prognostic factors.

Mozzillo N, Caraco C, Marone U, Di Monta G, Crispo A, Botti G World J Surg Oncol. 2013; 11:36.

PMID: 23379355 PMC: 3585715. DOI: 10.1186/1477-7819-11-36.


Role of radiotherapy in melanoma management.

Strojan P Radiol Oncol. 2012; 44(1):1-12.

PMID: 22933884 PMC: 3423668. DOI: 10.2478/v10019-010-0008-x.


Stage III thick (>4.0 mm) lower extremity melanoma: is timing of lymph node involvement a prognostic factor?.

Herman K, Wysocki W, Skotnicki P, Tabor J, Luczynska E, Komorowski A World J Surg. 2009; 33(3):469-74.

PMID: 19148700 DOI: 10.1007/s00268-008-9895-z.


Combined endoscopic and open inguinal dissection for malignant melanoma.

Schneider C, Brodersen J, Scheuerlein H, Tamme C, Lippert H, Kockerling F Langenbecks Arch Surg. 2003; 388(1):42-7.

PMID: 12690479 DOI: 10.1007/s00423-003-0357-7.